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background: The optimal timing of surgery for asymptomatic severe mitral regurgitation (MR) remains debatable. Excessive TGF-β activation is 
known to lead to pathological remodeling of the ventricular myocardium.
Methods: Myocardial tissue and blood samples were collected from patients with severe MR undergoing mitral valve surgery (MVR: N = 10), end 
stage heart failure undergoing Left Ventricular Assist Device implantation (LVAD: N = 7), and non-failing donor hearts (NF: N = 7). We examined 
plasma and myocardial TGF-β levels by bioassay, mRNA levels of TGF-β1, collagen type I, type III, MMP-2, and TGF-β downstream signals (Smad2 
and ERK1/2) by immunoblots. Data are shown as mean ±SEM.
results: See Table 1. Plasma TGF-β levels were significantly higher in LVAD than in MVR. Myocardial TGF-β was significantly higher in MVR and 
LVAD than in NF, but also surprisingly higher in MVR than in LVAD. Activation of TGF-β downstream signals, Smad2 and ERK1/2, were significantly 
increased in both MVR and LVAD compared with NF. Markers of myocardial fibrosis, Col I and MMP2 mRNA were significantly up-regulated in LVAD 
compared with MVR.
conclusion: Asymptomatic MVR with preserved ejection fraction (EF) showed significantly higher myocardial TGF-β activity levels than LVAD, 
indicating that MVR are already on the process of pathological remodeling despite a normal EF.
Baseline characteristics of myocardial and plasma TGF- β values
MVR (N=10) LVAD (N=7) NF (N=7) p Value
Age 64 ±11 52 ±16
Gender (M) 40% 71%
LV EF (%) 60.6 ±5.8 14 ±5
Plasma
free TGF-β (ng/ml) 1.47 ±0.50 5.28 ±3.36 0.0013
Plasma total TGF- β (ng/ml) 22.0 ±1.2 35.8 ±6.9 0.0023
Myocardial
free TGF- β (ng/mg) 1.03 ±0.29* 0.79 ±0.086* 0.27 ±0.095
*p<0.05 compared
with NF
Myocardial
total TGF- β (ng/ml) 2.73 ±0.74* 2.22 ±0.33* 1.124 ±0.183
*p<0.05
compared with NF
Myocardial TGF-b1/GAPDH mRNA 0.011 ±0.004 0.009 ±0.001 0.1124
pSmad2/Smad2 1.90 ±0.15* 2.23 ±0.42* 1.00 ±0.16
*
p<0.05 compared with NF
pERK1/2 / ERK1/2 4.60 ±0.45** 4.34 ±0.37** 1.00 ±0.21
**p <0.001
compared with NF
